Search research articles
Contact Us
Filters
Showing results (221-230 of 247) with videos related to
Page
of 25
Sort By:
Health Technology Assessment (Winchester, England)
|
December 21, 2021
Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs
Anthony G Marson, Girvan Burnside, Richard Appleton, et al.
Acta Neurochirurgica
|
October 3, 2018
Pharmacological management of post-traumatic seizures in adults: current practice patterns in the UK and the Republic of Ireland
Harry Mee, Angelos G Kolias, Aswin Chari, et al.
Frontiers in Pharmacology
|
June 28, 2021
Role of Common Genetic Variants for Drug-Resistance to Specific Anti-Seizure Medications
Stefan Wolking, Ciarán Campbell, Caragh Stapleton, et al.
Epilepsia
|
August 16, 2020
A multiorganism pipeline for antiseizure drug discovery: Identification of chlorothymol as a novel γ-aminobutyric acidergic anticonvulsant
Alistair Jones, Melissa Barker-Haliski, Andrei S Ilie, et al.
BMJ Medicine
|
June 16, 2025
Use of sodium valproate and other antiseizure drug treatments in England and Wales: quantitative analysis of nationwide linked electronic health records
Caroline E Dale, Rohan Takhar, Yat Yi Fan, et al.
Annals of Clinical and Translational Neurology
|
May 21, 2021
Assessing the role of rare genetic variants in drug-resistant, non-lesional focal epilepsy
Stefan Wolking, Claudia Moreau, Mark McCormack, et al.
British Journal of Clinical Pharmacology
|
April 19, 2026
HLA genotype testing for carbamazepine, oxcarbazepine and eslicarbazepine: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx)
Lucy Galloway, Cinzia Dello Russo, Nicholas Bass, et al.
Epilepsia
|
September 1, 2017
Comparative effectiveness of antiepileptic drugs in patients with mesial temporal lobe epilepsy with hippocampal sclerosis
Ganna Androsova, Roland Krause, Mojgansadat Borghei, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 20, 2025
Is resective surgery cost-effective for adults with epilepsy? A cost-utility analysis in a publicly funded healthcare system
Alexandra Bonnon, Paul Kopanidis, Sophia Kemmis-Betty, et al.
Epilepsia Open
|
March 15, 2019
A genome-wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepine
Bianca Berghuis, Caragh Stapleton, Anja C M Sonsma, et al.
Page
of 25
Search research articles
Search
Showing results (221-230 of 247) with videos related to
Sort By:
Page
of 25
Health Technology Assessment (Winchester, England)
|
December 21, 2021
Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs
Anthony G Marson, Girvan Burnside, Richard Appleton, et al.
Acta Neurochirurgica
|
October 3, 2018
Pharmacological management of post-traumatic seizures in adults: current practice patterns in the UK and the Republic of Ireland
Harry Mee, Angelos G Kolias, Aswin Chari, et al.
Frontiers in Pharmacology
|
June 28, 2021
Role of Common Genetic Variants for Drug-Resistance to Specific Anti-Seizure Medications
Stefan Wolking, Ciarán Campbell, Caragh Stapleton, et al.
Epilepsia
|
August 16, 2020
A multiorganism pipeline for antiseizure drug discovery: Identification of chlorothymol as a novel γ-aminobutyric acidergic anticonvulsant
Alistair Jones, Melissa Barker-Haliski, Andrei S Ilie, et al.
BMJ Medicine
|
June 16, 2025
Use of sodium valproate and other antiseizure drug treatments in England and Wales: quantitative analysis of nationwide linked electronic health records
Caroline E Dale, Rohan Takhar, Yat Yi Fan, et al.
Annals of Clinical and Translational Neurology
|
May 21, 2021
Assessing the role of rare genetic variants in drug-resistant, non-lesional focal epilepsy
Stefan Wolking, Claudia Moreau, Mark McCormack, et al.
British Journal of Clinical Pharmacology
|
April 19, 2026
HLA genotype testing for carbamazepine, oxcarbazepine and eslicarbazepine: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx)
Lucy Galloway, Cinzia Dello Russo, Nicholas Bass, et al.
Epilepsia
|
September 1, 2017
Comparative effectiveness of antiepileptic drugs in patients with mesial temporal lobe epilepsy with hippocampal sclerosis
Ganna Androsova, Roland Krause, Mojgansadat Borghei, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 20, 2025
Is resective surgery cost-effective for adults with epilepsy? A cost-utility analysis in a publicly funded healthcare system
Alexandra Bonnon, Paul Kopanidis, Sophia Kemmis-Betty, et al.
Epilepsia Open
|
March 15, 2019
A genome-wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepine
Bianca Berghuis, Caragh Stapleton, Anja C M Sonsma, et al.
Page
of 25